Effectiveness of Vinorelbine/Capecitabine (NX) versus Docetaxel/Doxorubicin/Cyclophosphamide (TAC) in patients non-responding to 2 cycles of neoadjuvant TAC chemotherapy: First Results of the phase III GEPARTRIO-Study by the German Breast Group

B.Gerber; von Minckwitz; J.U.Blohmer; A.Loehr; G.Raab; H.Eidtmann; J.Hilfrich; J.Huober; S.D.Costa; I.Zuna; M.Kaufmann

首页> 外文期刊>European Journal of Cancer Supplements >Effectiveness of Vinorelbine/Capecitabine (NX) versus Docetaxel/Doxorubicin/Cyclophosphamide (TAC) in patients non-responding to 2 cycles of neoadjuvant TAC chemotherapy: First Results of the phase III GEPARTRIO-Study by the German Breast Group

【24h】

Effectiveness of Vinorelbine/Capecitabine (NX) versus Docetaxel/Doxorubicin/Cyclophosphamide (TAC) in patients non-responding to 2 cycles of neoadjuvant TAC chemotherapy: First Results of the phase III GEPARTRIO-Study by the German Breast Group

机译：长春瑞滨/卡培他滨（NX）与多西他赛/阿霉素/环磷酰胺（TAC）对新辅助TAC化疗2个周期无反应的患者的疗效：德国乳腺癌小组进行的GEPARTRIO III期研究的初步结果

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2006年第2期|共2页
作者
B.Gerber; von Minckwitz; J.U.Blohmer; A.Loehr; G.Raab; H.Eidtmann; J.Hilfrich; J.Huober; S.D.Costa; I.Zuna; M.Kaufmann;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献

1. Neoadjuvant Vinorelbine–Capecitabine Versus Docetaxel–Doxorubicin–Cyclophosphamide in Early Nonresponsive Breast Cancer: Phase III Randomized GeparTrio Trial [J] . Gunter von Minckwitz Sherko Kümmel Petra Vogel Claus Hanusch Holger Eidtmann Jörn Hilfrich Bernd Gerber Jens Huober Serban Dan Costa Christian Jackisch Sibylle Loibl Keyur Mehta Manfred Kaufmann and On behalf of the German Breast Group Journal of the National Cancer Institute . 2008,第8期

机译：早期无反应性乳腺癌中新辅助长春瑞滨-卡培他滨与多西他赛-阿霉素-环磷酰胺的治疗：III期随机GeparTrio试验
2. Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial. [J] . von-Minckwitz G, Kummel S, Vogel P, Journal of the National Cancer Institute . 2008,第8期

机译：新的长春瑞滨-卡培他滨与多西他赛-阿霉素-环磷酰胺在早期无反应性乳腺癌中的疗效：III期随机GeparTrio试验。
3. A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer. [J] . Lee KS, Ro J, Nam BH, Breast cancer research and treatment. . 2008,第3期

机译：多西他赛/卡培他滨与阿霉素/环磷酰胺作为II / III期乳腺癌患者的主要化疗的III期随机试验。
4. A Randomized Phase II Trial of Capecitabine Plus Vinorelbine Followed by Docetaxel Versus Adriamycin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy for Breast Cancer [O] . Changhoon Yoo, Sung-Bae Kim, Jin-Hee Ahn, 2015

机译：卡培他滨加长春瑞滨后加多西他赛与阿霉素加环磷酰胺的随机二期临床试验多西他赛后加多西他赛对乳腺癌的新辅助化疗
5. PCN12 IMPACT OF ADJUVANT CHEMOTHERAPY WITH DOCETAXEL FOR EARLY BREAST CANCER: COST-EFFECTIVENESS ANALYSIS (CEA) OF A DOCETAXEL, DOXORUBICIN AND CYCLOPHOSPHAMIDE REGIMEN (TAC) VERSUS 5-FLUOROURACIL, DOXORUBICIN AND CYCLOPHOSPHAMIDE (FAC) IN FRANCE [O] . Miadi-Fargier H, Le Pen C, Woronoff-Lemsi MC, 2005

机译：PCN12辅助化疗与DOCETAXEL对早期乳腺癌的影响：DOCETAXEL，阿霉素和环磷酰胺（TAC）与5-氟尿嘧啶，阿霉素，环磷酰胺和环磷酰胺的成本效益分析（CEA）

Effectiveness of Vinorelbine/Capecitabine (NX) versus Docetaxel/Doxorubicin/Cyclophosphamide (TAC) in patients non-responding to 2 cycles of neoadjuvant TAC chemotherapy: First Results of the phase III GEPARTRIO-Study by the German Breast Group

著录项

相似文献

相关主题

期刊订阅